MX2022010093A - Tafoxiparina para el tratamiento de la preeclampsia. - Google Patents
Tafoxiparina para el tratamiento de la preeclampsia.Info
- Publication number
- MX2022010093A MX2022010093A MX2022010093A MX2022010093A MX2022010093A MX 2022010093 A MX2022010093 A MX 2022010093A MX 2022010093 A MX2022010093 A MX 2022010093A MX 2022010093 A MX2022010093 A MX 2022010093A MX 2022010093 A MX2022010093 A MX 2022010093A
- Authority
- MX
- Mexico
- Prior art keywords
- tafoxiparin
- preeclampsia
- treatment
- combination
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente invención se relaciona con el uso de la tafoxiparina derivada de heparina en el tratamiento de la preeclampsia (PE). El tratamiento puede ser monoterapia o terapia de combinación, donde la tafoxiparina se utiliza en combinación con un agente (fármaco) utilizado como terapia para cuidado estándar de la preeclampsia (PE).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE2000033 | 2020-02-17 | ||
PCT/EP2021/053733 WO2021165240A1 (en) | 2020-02-17 | 2021-02-16 | Tafoxiparin for the treatment of preeclampsia |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022010093A true MX2022010093A (es) | 2022-09-02 |
Family
ID=74668828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022010093A MX2022010093A (es) | 2020-02-17 | 2021-02-16 | Tafoxiparina para el tratamiento de la preeclampsia. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230144378A1 (es) |
EP (1) | EP4106765A1 (es) |
JP (1) | JP2023512920A (es) |
KR (1) | KR20220142508A (es) |
CN (1) | CN115103679A (es) |
AU (1) | AU2021223494A1 (es) |
BR (1) | BR112022014456A2 (es) |
CA (1) | CA3169421A1 (es) |
CL (1) | CL2022002239A1 (es) |
CO (1) | CO2022013055A2 (es) |
IL (1) | IL295184A (es) |
MX (1) | MX2022010093A (es) |
WO (1) | WO2021165240A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4272749A1 (en) | 2022-05-03 | 2023-11-08 | Dilafor AB | New medical use of tafoxiparin |
TW202406559A (zh) | 2022-05-03 | 2024-02-16 | 瑞典商迪拉佛公司 | 塔夫西肝素(tafoxiparin)之新穎醫藥用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL127896A0 (en) * | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
SE521676C2 (sv) | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
US20070292421A1 (en) * | 2005-07-28 | 2007-12-20 | Feinberg Bruce B | Method for treating preeclampsia |
WO2013095279A1 (en) | 2011-12-19 | 2013-06-27 | Dilafor Ab | Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use |
NZ631279A (en) | 2012-03-26 | 2016-06-24 | Dilafor Ab | Method for treatment of labor arrest |
MY175743A (en) | 2012-03-26 | 2020-07-07 | Dilafor Ab | Combination treatment comprising sulphated glycosaminoglycans for inducing labor |
CN104284667A (zh) | 2012-05-08 | 2015-01-14 | 迪乐方有限责任公司 | 采用化学修饰的肝素或硫酸乙酰肝素和子宫收缩剂的产后出血的治疗 |
GB2515315A (en) | 2013-06-19 | 2014-12-24 | Dilafor Ab | New Processes |
-
2021
- 2021-02-16 AU AU2021223494A patent/AU2021223494A1/en active Pending
- 2021-02-16 JP JP2022543404A patent/JP2023512920A/ja active Pending
- 2021-02-16 CN CN202180014827.6A patent/CN115103679A/zh active Pending
- 2021-02-16 US US17/800,131 patent/US20230144378A1/en active Pending
- 2021-02-16 IL IL295184A patent/IL295184A/en unknown
- 2021-02-16 CA CA3169421A patent/CA3169421A1/en active Pending
- 2021-02-16 KR KR1020227032283A patent/KR20220142508A/ko unknown
- 2021-02-16 WO PCT/EP2021/053733 patent/WO2021165240A1/en unknown
- 2021-02-16 MX MX2022010093A patent/MX2022010093A/es unknown
- 2021-02-16 EP EP21706523.4A patent/EP4106765A1/en active Pending
- 2021-02-16 BR BR112022014456A patent/BR112022014456A2/pt unknown
-
2022
- 2022-08-17 CL CL2022002239A patent/CL2022002239A1/es unknown
- 2022-09-14 CO CONC2022/0013055A patent/CO2022013055A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN115103679A (zh) | 2022-09-23 |
WO2021165240A1 (en) | 2021-08-26 |
CA3169421A1 (en) | 2021-08-26 |
KR20220142508A (ko) | 2022-10-21 |
US20230144378A1 (en) | 2023-05-11 |
JP2023512920A (ja) | 2023-03-30 |
BR112022014456A2 (pt) | 2022-09-13 |
CO2022013055A2 (es) | 2022-09-30 |
AU2021223494A1 (en) | 2022-08-04 |
IL295184A (en) | 2022-09-01 |
CL2022002239A1 (es) | 2023-04-10 |
EP4106765A1 (en) | 2022-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021013830A (es) | Inhibidores de ezh2 para tratar linfomas. | |
MX2022009164A (es) | N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos. | |
MX2017017138A (es) | Conjugados homogeneos especificos de sitio con inhibidores de ksp. | |
SG10201902429PA (en) | Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | |
MX2017013142A (es) | Terapia combinada para tratar cáncer. | |
MX2016008013A (es) | Conjugados de farmacos anticuerpo (adcs) con inhibidores de ksp. | |
PH12014501815A1 (en) | Purinone compounds as kinase inhibitors | |
MY182590A (en) | Benzylamine derivatives | |
MX2016004580A (es) | Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia. | |
MX2019009227A (es) | Métodos para tratar cáncer con inhibidores de hsp90. | |
BR112015026247A2 (pt) | métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor | |
MX2021010173A (es) | Compuestos con actividad inductora de ferroptosis y métodos de uso. | |
MX2023014492A (es) | Compuestos utiles en la terapia para el vih. | |
MX2018010223A (es) | Terapia combinada para tratamiento de cancer de ovario. | |
MX2022010093A (es) | Tafoxiparina para el tratamiento de la preeclampsia. | |
BR112022001341A2 (pt) | Inibidores de enzima | |
MX2019013862A (es) | Terapia de combinacion. | |
MX2020001727A (es) | Terapia de combinacion. | |
MX2014010940A (es) | El uso de antitrombina en el tratamiento de preeclampsia. | |
MX2021001612A (es) | Compuestos utiles en terapia del vih. | |
MX2018008640A (es) | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano. | |
MX2022000811A (es) | Inhibidores de enzimas. | |
MX2021000542A (es) | Apirasas solubilizadas, metodos y usos. | |
PH12015501492A1 (en) | Benzylamine derivatives | |
MX2021011289A (es) | Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas. |